Articles from Hims & Hers Health, Inc.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2024 in a shareholder letter that is posted at investors.hims.com.

Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on Monday, May 6, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company’s Board of Directors.

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that members of the company’s management team will be participating in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024. All events will be webcast live and archived on the Hims & Hers investor relations website at https://investors.forhims.com.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSEHIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2023 in a shareholder letter that is posted at investors.hims.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer. Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding.

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today unveiled Weight Loss by Hims & Hers, a comprehensive and customizable clinical approach specifically designed to help people achieve their individual weight-loss goals. The company also announced that Craig Primack, MD, FACP, FAAP, FOMA, a pioneer in the field of clinical obesity medicine, has joined the company as SVP of Weight Management.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. Hims & Hers intends to use the program to repurchase shares on a discretionary basis from time to time, subject to general business and market conditions and other investment opportunities, through open market purchases, privately negotiated transactions or other means, including through 10b5-1 trading plans. This repurchase program may be commenced, suspended or discontinued at any time.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSEHIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to transform healthcare by giving providers a more intelligent and informed way to deliver personalized care to patients with more effective and precise treatments and medications.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced communications veteran Khobi Brooklyn will further position Hims & Hers at the forefront of personalized healthcare as its Chief Communications Officer. Brooklyn’s extensive communications leadership experience includes roles at global brands such as Tesla, Nike, Square and Aurora. In her role as CCO, Brooklyn will strengthen the Hims & Hers brand and increase awareness by spearheading the company’s communications function which includes corporate, consumer and internal, reporting to the CEO.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the second quarter ended June 30, 2023.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced a new approach to enable providers to personalize sexual health treatment for men that also supports cardiovascular health. Through Heart Health by Hims, providers will be able to personalize treatments to combine active ingredients found in clinically proven medications to address multiple conditions in one pill, demonstrating Hims & Hers’ rapidly advancing technology and pharmacy capabilities.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2023 financial results after the market closes on Monday, August 7, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today unveiled the latest innovative additions to hair care offerings provided by Hers. Available now, the Hair Blends line provides access to formulations that are designed for women who may benefit from more personalized options to treat hair loss.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, announced today that Hard Mints by Hims are now available for people across the United States. Hims anticipates they will also be available across the United Kingdom in June.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the first quarter ended March 31, 2023.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has been certified as a great place to work this month by the independent analyst Great Place to Work® for the year 2023.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is adding five new members to its Medical Advisory Board. The group of specialists advises the company as it works to create access to safe, high-quality, personalized care and treatment. These new advisors represent a diverse group of medical experts specializing in medicine related to obesity, menopause, and cardiometabolic health.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is today announcing Hims Dandruff Detox, a unique shampoo formulated with doctors that both fights dandruff and supports scalp health. This powerful and gently-cleansing formula was developed with doctors to be vegan, cruelty-free and free of parabens, phthalates, sulfates and dyes.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company’s Senior Vice President of Mental Health.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSEHIMS), the leading health and wellness platform, is aware of the current actions taken by the Federal Deposit Insurance Corporation with respect to Silicon Valley Bank (“SVB”). The Company has limited cash exposure resulting from the liquidity concerns at SVB. The vast majority of the Company’s cash and short-term investments are held via third-party custodians other than SVB. Additionally, the Company does not have any debts or current lines of credit directly impacted by these events.

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSEHIMS), the leading health and wellness platform, today reported financial results for the fourth quarter and full year ended December 31, 2022.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, is announcing the launch of Hard Mints by Hims. This compounded chewable, mint-flavored tablet is available by prescription in a variety of dosages designed to give providers more options in finding the best outcomes for their patients experiencing symptoms of erectile dysfunction. Leveraging the same active ingredients as Cialis©, Viagra©, Levitra© and Stayxn©, Hard Mints by Hims is a highly personalized treatment that can be tailored to each individual’s health needs and preferences by their medical provider.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that it will report fourth quarter and full year 2022 financial results after the market closes on Monday, February 27, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, is today announcing a new line of thoughtfully crafted volumizing shampoos and conditioners that are formulated with Biovolume 128™, which has been shown to increase hair volume. These vegan, paraben-, phthalates-, sulfate-, dye- and cruelty-free formulas have been developed specifically to boost the volume of those who have fine, flat, or limp hair.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, announced today that actress Kristen Bell is joining Hers as its first Mental Health Ambassador. Sharing a common goal of helping people feel confident when it comes to taking care of their mental health, Bell and Hers are working together to combat stigma surrounding mental health and encourage conversation and exploration of treatment for people struggling with anxiety and depression.

Hims & Hers Health, Inc. (“Hims & Hers,” NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced the return of Dr. Pat Carroll as Chief Medical Officer. Dr. Carroll rejoins Hims & Hers to redouble the company’s focused clinical operations, which ensure every consumer on the platform receives the highest-quality care.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever Chief Pharmacy & Innovation Officer.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, and one of the nation’s premier health systems, ChristianaCare, today announced a partnership that will expand access to healthcare services and create a more seamless care journey for patients. The partnership will benefit customers in Delaware, Maryland, New Jersey and Pennsylvania, and expands the Hims & Hers’ partnership network with providers to now include 10 states and Washington D.C.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today reported financial results for the third quarter ended September 30, 2022.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that it will report third quarter 2022 financial results after the market closes on Monday, November 7, 2022. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, has added two high-profile executives to its leadership ranks as the company continues to deliver improving financial performance, including rapid topline growth and increasing scale. Silicon Valley communications veteran Brian O’Shaughnessy has been appointed the company’s first Chief Communications Officer. Josh Krueger has been named VP of Fulfillment Operations, bringing over a decade of experience in fulfillment leadership roles at Walmart and Amazon.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern, personalized health and wellness experiences to consumers, is today releasing its first annual “Let’s Talk About Sex: The 2022 Report.” For how popular a topic sex is—online searches for “sex” yield nearly 11 billion results, 1.5X more results than people on Earth—a third of Americans say most of their sex education comes from pornography. The 2022 Report serves as a new educational resource, designed to uncover behaviors, trends, fears, fantasies and realities about sex in America.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that both the Hims and Hers mobile apps are now available on Android via the Google Play Store. This follows the successful rollout of the apps on Apple's iOS earlier this year, and means that the Hims and Hers apps are now accessible to anyone with an Apple or Android device.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today reported financial results for the second quarter ended June 30, 2022.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, is today revealing Hers Wellness Essentials, six new supplements formulated specifically for women. The new line includes probiotic supplements that support women’s general health, mental wellness, gut health, digestive health and skin health, as well as a daily libido supplement, are now available at select CVS Pharmacy locations nationwide, CVS.com, ForHers.com, and now the new Hers App. These supplements use effective formulas with naturally-occurring ingredients and trusted formulas to help address a wide range of women’s wellness concerns, allowing women to build a supplements routine based on their needs.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides access to related prescription fulfillment, today reported financial results for the first quarter ending March 31, 2022.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its first quarter 2022 financial results on Monday, May 9, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, and Carbon Health, a leading national healthcare provider, are partnering to enable easy and comprehensive access to a broader range of care options through the Hims & Hers platform. Hims & Hers already offers a wide range of care options, and those options will grow with this collaboration by enabling licensed medical professionals on the Hims & Hers platform to direct patients to Carbon Health if they present with complex medical histories, conditions, or concerns that require further clinical attention.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has unveiled the expansion of both the Hims and Hers skincare collections, offering new skincare products to support a wide range of skincare concerns. This includes a facial cleanser, moisturizer, daily SPF, spot corrector and face oil.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today that co-Founder and Chief Executive Officer, Andrew Dudum, and Chief Financial Officer, Yemi Okupe, will participate in a fireside chat at Citi’s 2022 Virtual Health Conference, Thursday, February 24 at 3:30 pm Eastern time.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides access to related prescription fulfillment, today reported financial results for the fourth quarter and full year ending December 31, 2021.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched three new supplements that are designed to help consumers support their mental wellness, including sleep, stress, and lack of focus. These new wellness supplements are now available on forhims.com and forhers.com, as well as select Target and Walgreens stores and UrbanOutfitters.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its fourth quarter and fiscal year 2021 financial results on Tuesday, February 22, 2022 at 4:00 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced the next step in its effort to fundamentally reshape what it means to access and experience great modern healthcare with the launch of the Hims & Hers mobile platform. The app is available for download now on iOS here.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today the launch of its high quality hair care solutions at select Walmart retail locations nationwide and on walmart.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a number of leadership appointments that firmly position the company for success in pursuit of its mission to transform the legacy healthcare and wellness industry. The company has named Yemi Okupe – a PayPal, eBay, Google, Braintree, and Uber veteran with a decade of experience scaling high-growth, industry-disrupting companies – as Chief Financial Officer. Additionally, Hims & Hers Chief Medical Officer Dr. Patrick Carroll is being elevated to the company’s Board of Directors.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched two new prescription offerings -- Topical Finasteride & Minoxidil Spray and Oral Spironolactone -- to provide women with more effective solutions to address hair loss, which 1 in 3 women -- roughly 30 million women in the US alone -- experience at some time in their lives.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has appointed Jay Spitzer, CFA as Senior Vice President of Investor Relations.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform, is expanding the size and scope of its Medical Advisory Board as it continues expanding more recent medical verticals such as mental health and primary care, and further growing early focus areas, such as sexual health, dermatology, and hair loss. The Medical Advisory board -- which advises the company as it works to create access to safe, high-quality care and treatment -- is growing from five to 15 members. The new advisors represent a diverse group of medical experts with specific expertise in the fields of infectious disease, primary care, mental health, dermatology, sexual health, and more.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced its largest on-demand delivery partnership with Uber Technologies, Inc. (NYSEUBER), to bring a wide array of the company’s personal care products to customers through the Uber Eats app.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced bundles of some of their top-selling skin and hair products, perfect for all types of gifting needs this holiday season.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced it will start offering its products in Amazon’s store to increase the accessibility of Hims & Hers supplements, sexual health and wellness products and hair care offerings, including a few product bundles exclusively available through the new official Hims & Hers store on Amazon.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today unveiled its plans to provide more complete, holistic and personalized care experiences with the launch of the Hims & Hers mobile app. The Company intends to begin rolling out the app to its over 500,000 subscription members (“Members”) in the coming weeks.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the third quarter ending September 30, 2021.

Hims & Hers Health, Inc. (NYSEHIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today that CEO Andrew Dudum and Chief Medical Officer Patrick Carroll will participate in the Credit Suisse 30th Annual Healthcare Conference with one-on-one meetings throughout the day on Thursday, November 11, 2021.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, and Walgreens today announced a collaboration to provide greater access to high quality health and wellness solutions. This will include the availability of Hims & Hers supplements and sexual health and wellness solutions, which will be offered at Walgreens retail locations nationwide and on walgreens.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today introduced Climax Delay Wipes as a new non-prescription offering within Hims’ Sexual Health category on forhims.com. The non-prescription single-use benzocaine wipes provide a simple and effective way to maintain erections for longer periods of time.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release fiscal third quarter financial results on Wednesday, November 10, 2021 after market close, with a conference call to follow at 5:00 p.m. E.T.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a partnership with The Vitamin Shoppe, a global, omni-channel specialty retailer of health and wellness solutions. Starting today, Hims & Hers haircare products are now available both online at vitaminshoppe.com and in-store at over 280 locations of The Vitamin Shoppe.

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSEHIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently expanded its women’s health offerings with the recent launch of a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. This most recent holistic offering reiterates the company’s mission to provide consumers with products - both over the counter and prescription, as recommended by medical practitioners - access to the health solutions they need without the hassles accompanied by traditional methods.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a partnership with REVOLVE (NYSERVLV), a premium lifestyle fashion retailer and go-to online source for discovery and inspiration with Millennial and Generation Z consumers. REVOLVE is adding a diverse range of health and wellness solutions from Hims & Hers to its site, REVOLVE.com.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, announced today that its management team will participate at two upcoming conferences:

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced it has partnered with American professional football tight end Rob Gronkowski to bring increased awareness to men’s health topics and treatment from hair loss to mental health with a series of new advertising campaigns and social content.

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced that Spencer Lee plans to step down from his role as the company’s Chief Financial Officer. Lee, who joined the company in March 2019, will lead a six month transition plan and continue to support the company until a new CFO is appointed to ensure a smooth transition. The search for a new Chief Financial Officer has begun and is being led by Co-Founder and CEO Andrew Dudum and Board Member and Audit Chair, David Wells, the former CFO of Netflix.

On the heels of strong Q2 earnings, Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS) has appointed Mike Chi as the company’s first-ever Chief Growth Officer. Chi brings a wealth of experience in the women's market and will be responsible in this new role for driving continued growth across Hims & Hers’ multi-specialty telehealth platform.

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the second quarter ending June 30, 2021.